Research at the BRTC is focused primarily on the development and evaluation of psychotherapies for individuals with severe and chronic personality disorders. Research focuses on the understanding, assessment and treatment of suicidal behaviors. To date, most research has focused on treatment development for suicidal individuals meeting criteria for Borderline Personality Disorder. Most research has been funded by the National Institutes of Health.
CURRENTLY ACCEPTING CLIENTS FOR THE FOLLOWING STUDIES:
1. CARES: Collaborative Adolescent Research on Emotion and Suicide
PURPOSE OF THE CARES CLINIC:
Seattle Children’s Hospital and the University of Washington are providing specialty treatment for adolescents engaging in suicidal behaviors and studying how to help reduce them. We are accepting teenagers (ages 13–18) that are seeking treatment for self-injurious behaviors.
WHAT’S INVOLVED:
Eligible teen and parent will participate in 6 months of treatment. Treatment is typically weekly and includes both individual and group components. Teens and parents also complete questionnaires and interviews.
Interested families can get more information by:
Contacting the CARES Study at: 206–221-CARE
2. Assessment of suicidal thoughts, feelings and behaviors
This study is focused on the development and initial evaluation of brief methods to assess individuals who are currently experiencing suicidal thoughts and urges.
DBT is a comprehensive, cognitive-behavioral treatment for suicidal individuals that has been shown effective in reducing the primary problems it is designed to treat; namely, the frequency and severity of self-injurious and suicidal behavior.
However, DBT is a long-term treatment. The present study will involve interview and questionnaire assessments and the opportunity to learn skills to deal with suicidal thoughts and urges that occur in your daily life. Further, you will be asked to provide feedback on your experience.
The study will require approximately 2 hours of participation.
For more information please call us at 206–543-2505.